Not Applicable.

Uses and Use Restrictions

The assistance can be applied to supplies, equipment, personnel, job training, and/or travel needed to conduct retail food surveillance activities as defined in the cooperative agreement and referenced in the NARMS retail food surveillance protocol.

Assistance can be applied to improving the way antibiotic resistance surveillance samples are collected and processed, improve microbiological testing standards, improve quality assurance practices, improve collaboration and coordination of surveillance activities with the FDA, improve the exchange of relevant and complete surveillance data with the FDA, improve the use of data to inform program and policy development, improve data for education on current and emerging hazards, improve awareness of antimicrobial resistance among the public, improve the identification of foodborne illness outbreaks and coordinate outbreak investigations with the FDA, improve the way surveillance data are collected and analyzed, and for conducting ad hoc pilot studies as needed for consensus definitions.

Funds are restricted from being used for the following: alterations or renovations; construction; fund-raising activities; political education and lobbying; vocational rehabilitation.

There is approximately $2,500,000 available for up to 30 cooperative agreements.

People Building Stronger Communities

Head Start Program to Include Toledo

Hispanics to Benefit from ACA Coverage

Nepal\'s Civil Society Members Rally against Chief Justice

Lenovo Looking to Acquire RIM

Disruptive Tensions of Open-Access Publishing with MOOCs

Western Cape: Cultivating Partnerships for Agriculture and Rural Economic Development

Boston Teens Gather Together for Summer\'s Largest Civic Engagement Forum

Community Health Workers Get Promising Opportunities at the Height of Health Reform

Smaller Communities Have Higher Homelessness Rates

Eligibility Requirements

Applicant Eligibility

Applicants should review the individual funding opportunity announcement issued under this CFDA program to see which applicant organizations are eligible to apply.

Beneficiary Eligibility

Improving antimicrobial resistance surveillance, food safety, and antimicrobial drug approvals for animals and humans.

Credentials/Documentation

A nonprofit private entity must provide evidence of its nonprofit status. Applicants should review the individual funding opportunity announcement issued under this CFDA program for any required proof of certification which must be submitted prior to or simultaneous with submission of an application. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is not applicable.

Environmental impact information is not required for this program.

This program is excluded from coverage under E.O.

12372.

Application Procedures

2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. To apply, access the announcement through www.grants.gov. Enter the CFDA# and follow the website instructions. Applications submitted after the deadlines will not be accepted for review. The submission deadline will not be extended. Applications which do not conform to the requirements of the grant announcement will not be accepted for review. Applications may only be submitted electronically via www.grants.gov. Any applications submitted via any other means of electronic communication, including facsimile or electronic mail, will not be accepted for review. Applicants should review the individual funding opportunity announcement issued under this CFDA program for specific application procedures.

Award Procedures

Applications will be screened upon receipt. Those that are judged to be ineligible will not be reviewed. Accepted applications will be subject to objective review for technical merit. Applications will be evaluated by an objective review committee composed of experts. Final funding decisions will be determined by the NVPO Office Director; taken into consideration are the recommendations of the review committee; program needs, stated preferences; geographic location. All applicants are notified in writing of actions taken on their applications. A Notice of Award is issued for those applications that are approved and funded. Applicants should review the individual funding opportunity announcement issued under this CFDA program to see the specific award procedures that apply.

Deadlines

Contact the headquarters or regional office, as appropriate, for application deadlines.

Authorization

Section 1702(a) [42 U.S.C. 300u-1(a)] and Section 1703(a) and (c) [42 U.S.C. 300u-2(a) and (c)] of the Public Health Service Act, as amended.

Range of Approval/Disapproval Time

From 60 to 90 days.

Appeals

Not Applicable.

Renewals

Renewals are permitted as indicated in the published funding opportunity announcement issued under this CFDA program. Renewal awards may be approved pending availability of funding and evidence of satisfactory progress and compliance.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula. This program has no matching requirements. This program does not have MOE requirements.

Length and Time Phasing of Assistance

The length of support will depend on the nature of the projects, program relevance and the availability of funds. Awards are usually made for a 12-month period with recommendation of up to 4 years of additional support. Applicants should review the individual funding opportunity announcement issued under this CFDA program to see the specific available length and time that apply. See the following for information on how assistance is awarded/released: The Notice of Award (NoA) is the legal document issued to notify grantees that an award has been made and that funds may be requested from the designated HHS payment system or office. A NoA is issued for the initial budget period, if subsequent budget periods are also approved, the NoA will include a reference to those budgetary commitments. Funding for subsequent budget periods are generally provided in annual increments following the annual assessment of the project?s progress. This funding is also contingent on the availability of funds. Funds are made available through the DHHS Payment Management System (PMS). Cooperative Agreements may not exceed 5 years (subject to the availability of funds). Necessary instructions for the appropriate type of payment will be issued at the time an award is made.

Post Assistance Requirements

Reports

Program reports are required as stated in the Funding Opportunity Announcement and the Terms and Conditions of award. Bi-annual Progress Reports must be submitted each year.

A Final Report will be due 90 days after the end of the project period.

No cash reports are required.

A revised work plan must be submitted each year to indicate any service and/or partnership revisions.

Federal Financial Reporting (FFR) SF425 are required annually and must be submitted via eRA Commons.

Final FFR will be due 90 days after the end of the project period.

The FFR has a dedicated section to report Federal cash receipts and disbursements.

For recipients this information must be submitted quarterly directly to the Payment Management System (PMS) using the web-based tool.

Quarterly reports are due 30 days following the end of each calendar quarter.

Performance monitoring is required as stated in the Funding Opportunity Announcement and the Terms and Conditions of Award.

A final performance report is due 90 days following the end of the project period.

Audits

In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503.

Records

HHS and the Comptroller General of the United States or any of their authorized representatives shall have the right of access to any books, documents, papers, or other records of a grantee, sub-grantee, contractor, or subcontractor, which are pertinent to the HHS grant, in order to make audits, examinations, excerpts and transcripts. In accordance with 45 CFR, Part 74.53 and 45 CFR, Part 92, grantees are required to maintain grant accounting records 3 years after the end of a project period. If any litigation, claim, negotiation, audit or other action involving the records has been started before the expiration of the 3-year period, the records shall be retained until completion of the action and resolution of all issues which arise from it, or until the end of the regular 3-year period, whichever is later.

Financial Information

Account Identification

75-0600-0-1-554.

Obigations

(Cooperative Agreements) FY 16 $2,310,556; FY 17 est $2,500,000; and FY 18 est $2,500,000

Range and Average of Financial Assistance

Estimated $2,500,000 available for anticipated 30 awards.

Regulations, Guidelines, and Literature

Applicants should review the individual Funding Opportunity Announcement issued under this CFDA program to see the specific regulations, guidelines, and/or literature that applies. HHS Grants Policy Statement is available online: http://www.hhs.gov/asfr/ogapa/aboutog/hhsgps107.pdf.

Information Contacts

Regional or Local Office

None.

Headquarters Office

Patrick McDermott 8401 Muirkirk Rd, Laurel, Maryland 20708 Email: patrick.mcdermott@fda.hhs.gov Phone: 240-402-0891

Criteria for Selecting Proposals

Applicants should review the individual Funding Opportunity Announcement issued under this CFDA program to see the specific evaluation criteria that applies.